Clinical Trials in Chongqing, China
Locations / Chongqing, China
Delta Trials lists 2,741 clinical trials conducted in Chongqing, China, making it a notable site of clinical research activity. These trials addressing 2,121 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 110 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Chongqing research landscape.
2741
Total Trials
2121
Conditions
110
Terminated since 2020
Browse by condition (2121 total)
- Non-small cell lung cancer 93 trialsAll Non-small cell lung cancer trials
- Breast cancer 39 trialsAll Breast cancer trials
- Diabetes mellitus, type 2 39 trialsAll Diabetes mellitus, type 2 trials
- Asthma 35 trialsAll Asthma trials
- Chronic hepatitis b 34 trialsAll Chronic hepatitis b trials
- Hepatocellular carcinoma 30 trialsAll Hepatocellular carcinoma trials
- Gastric cancer 27 trialsAll Gastric cancer trials
- Primary aldosteronism 27 trialsAll Primary aldosteronism trials
- Hypertension 27 trialsAll Hypertension trials
- Type 2 diabetes mellitus 26 trialsAll Type 2 diabetes mellitus trials
- Carcinoma, non-small-cell lung 25 trialsAll Carcinoma, non-small-cell lung trials
- Obesity 25 trialsAll Obesity trials
- Hepatitis b, chronic 23 trialsAll Hepatitis b, chronic trials
- Cervical cancer 23 trialsAll Cervical cancer trials
- Ovarian cancer 23 trialsAll Ovarian cancer trials
- Type 2 diabetes 23 trialsAll Type 2 diabetes trials
- Stroke 23 trialsAll Stroke trials
- Colorectal cancer 22 trialsAll Colorectal cancer trials
- Advanced solid tumors 20 trialsAll Advanced solid tumors trials
- Chronic obstructive pulmonary disease 19 trialsAll Chronic obstructive pulmonary disease trials